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Terminology
• «Cavernous hemangioma» > Venous malformation
• «Cystic hygroma» > Lymphatic malformation
• Term «Hemangioma» misused (71.3%)
• Chance of wrong treatment in 20.3% of cases
Hassanein AH, Mulliken JB, Fishman SJ et al.Evaluation of terminology for vascular anomalies in current
literature.Plast Reconstr Surg. 2011 Jan;127(1):347-51.
Imaging
MRI: T2-weighted fat-sat.        T1-weighted image post KM      

Venous Malformation
• Most frequent slow flow malformation
• Congenital (often seen at birth)
• 90% with cutaneous involvement with bluish appearance of 
cutaneous lesions
• Somatic mutation (except GVM and cutaneomucosal venous 
malformations)
HASSANEIN AH, MULLIKEN JB, FISHMAN SJ ET AL. VENOUS MALFORMATION: RISK OF PROGRESSION DURING CHILDHOOD
AND ADOLESCENCE. ANN PLAST SURG. 2012 FEB;68(2):198-201.
Risk of Progression in VM 
Venous Malformation
Imaging features
• MRI:
• Phleboliths
• Thin membranes
• Fluid filled spaces
• Fluid-Fluid levels 
• US:
• Compressible
• Slow venous flow, if any
2 YOF with multiple VMs including large tongue lesion. 
1st procedure: STS 5 mL, ETOH 3 mL
Treatment with Sclerotherapy
Lymphatic Malformation
• Abnormal development of the lymphatic vessels
• Common sites: neck, axilla, and pelvis
• Three subtypes:
 Microcystic, macrocystic, combined
• Intermittent swelling:
 Intralesional bleeding, Infection,
systemic illnesses
Macrocystic Lymphatic Malformation
Sclerotherapy: Doxycyline, Ethanol
Treatment
Microcystic Lymphatic Malformation
Sclerotherapy: Bleomycin, Doxycyline, Ethanol
Arteriovenous Malformation (AVM)
Four clinical stages (Schobinger):
1. Quiescent
2. Expansion
3. Destruction (ulceration, bleeding and pain)
4. High outflow heart failure (rare)
Arteriovenous Malformation (AVM)

LIU AS, MULLIKEN JB, ZURAKOWSKI D ET AL. EXTRACRANIAL ARTERIOVENOUS MALFORMATIONS: NATURAL PROGRESSION AND
RECURRENCE AFTER TREATMENT. PLAST RECONSTR SURG. 2010 APR;125(4):1185-94.
Risk of Recurrence
Embolization Nidus (AVM)
Pre embolization
Post embolization
3 months later
Arteriovenous Malformation (AVM)
Embolization of draining vein (AVM)
Clemens RK, Alomari AI. Transcutaneous treatment of an intraosseous arteriovenous malformation. CIRSE 2013. Abstr. Book:394.
Medical treatment of vascular malformations
• Limited, off-label use
• Addition to surgical and/or interventional treatment
• Reduce risk of recurrence
• Enhance primary treatment effect
• m-TOR-inhibitor (Sirolimus) for AVMs and BRBNS
• PI3K inhibitors
• Bevacizumab and interferon reduce venous recanalization
Summary
• Interventional
• First or additional
• Embolization for fast-flow
• Sclerotherapy for slow-flow
• Surgical
• Total excision possible
• Overgrowth, tissue
• «Deal» > function, esthetic
• Medical
• Limited, additional, off-label use
RARELY CURABLE, CONTROL OF SYMPTOMS, MULTIPLE 
SESSIONS
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